Regeneron Pharmaceuticals | REGN - Pe Kurs-Gewinn

Aktienkurs
714.89
Täglich Wechseln
5.79 0.82%
Monatlich
-6.90%
Jährlich
35.45%
Q2 Prognose
700.09




Pe Veränderung Datum
AbbVie 23.03 1 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
Astellas Pharma 15.48 8.16 2026-03
AstraZeneca 29.59 2.3 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 17.7 2.07 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 24.53 0.91 2026-03
Kyowa Hakko Kirin 15.88 3.85 2026-03
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 20.17 2.32 2026-03
Novartis 17.79 1.74 2025-12
Pfizer 9.32 5.16 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Roche Holding 16.09 3.51 2025-12
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-12
Teva Pharmaceutical Industries 10.07 0.04 2026-03
United Therapeutics 20.42 3.1 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03